JP2024521444A5 - - Google Patents

Info

Publication number
JP2024521444A5
JP2024521444A5 JP2023576064A JP2023576064A JP2024521444A5 JP 2024521444 A5 JP2024521444 A5 JP 2024521444A5 JP 2023576064 A JP2023576064 A JP 2023576064A JP 2023576064 A JP2023576064 A JP 2023576064A JP 2024521444 A5 JP2024521444 A5 JP 2024521444A5
Authority
JP
Japan
Prior art keywords
item
cancer
sequence
rna
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576064A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521444A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033091 external-priority patent/WO2022261490A2/en
Publication of JP2024521444A publication Critical patent/JP2024521444A/ja
Publication of JP2024521444A5 publication Critical patent/JP2024521444A5/ja
Pending legal-status Critical Current

Links

JP2023576064A 2021-06-10 2022-06-10 環状ｒｎａ組成物及び方法 Pending JP2024521444A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163209271P 2021-06-10 2021-06-10
US63/209,271 2021-06-10
US202263311923P 2022-02-18 2022-02-18
US63/311,923 2022-02-18
PCT/US2022/033091 WO2022261490A2 (en) 2021-06-10 2022-06-10 Circular rna compositions and methods

Publications (2)

Publication Number Publication Date
JP2024521444A JP2024521444A (ja) 2024-05-31
JP2024521444A5 true JP2024521444A5 (enExample) 2025-06-06

Family

ID=83081188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576064A Pending JP2024521444A (ja) 2021-06-10 2022-06-10 環状ｒｎａ組成物及び方法

Country Status (11)

Country Link
US (1) US20250283073A1 (enExample)
EP (1) EP4352234A2 (enExample)
JP (1) JP2024521444A (enExample)
KR (1) KR20240019791A (enExample)
AU (1) AU2022288705A1 (enExample)
BR (1) BR112023025515A2 (enExample)
CA (1) CA3219932A1 (enExample)
IL (1) IL308746A (enExample)
MX (1) MX2023014702A (enExample)
TW (1) TW202317767A (enExample)
WO (1) WO2022261490A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022332372B2 (en) 2021-08-27 2025-12-04 Peking University Constructs and methods for preparing circular rna
AR127073A1 (es) 2021-09-17 2023-12-13 Flagship Pioneering Innovations Vi Llc Composiciones y métodos para producir polirribonucleótidos circulares
CN114214237B (zh) * 2021-12-23 2023-06-16 南京大学 一种洗脱细胞表面吸附纳米颗粒的方法
TW202334412A (zh) * 2022-01-11 2023-09-01 北京大學 針對 sars-cov-2 變體的環狀 rna 疫苗及其使用方法
EP4466029A1 (en) * 2022-01-21 2024-11-27 Orna Therapeutics, Inc. Systemic administration of circular rna polynucleotides encoding muscle proteins or protein complexes
AU2023240827A1 (en) * 2022-03-21 2024-07-18 Bio Adventure Co., Ltd. Internal ribosome entry site (ires), plasmid vector and circular mrna for enhancing protein expression
US12297285B2 (en) * 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA
CN116064531B (zh) * 2022-09-07 2024-04-02 昆明理工大学 一种抑制cvb5病毒复制的长链非编码rna及应用
TW202428289A (zh) 2022-11-08 2024-07-16 美商歐納醫療公司 環狀rna組合物
EP4634390A2 (en) 2022-12-15 2025-10-22 Orna Therapeutics, Inc. Circular rna compositions and methods
EP4680750A1 (en) 2023-03-15 2026-01-21 Flagship Pioneering Innovations VI, LLC Compositions comprising polyribonucleotides and uses thereof
EP4680276A1 (en) 2023-03-15 2026-01-21 Flagship Pioneering Innovations VI, LLC Immunogenic compositions and uses thereof
KR20240159310A (ko) * 2023-04-28 2024-11-05 주식회사 메디치바이오 신규한 이온화지질을 이용한 지질나노입자 조성물
WO2024205657A2 (en) * 2023-03-29 2024-10-03 Orna Therapeutics, Inc. Lipids and lipid nanoparticle compositions for delivering polynucleotides
WO2024200820A1 (en) 2023-03-30 2024-10-03 Ose Immunotherapeutics Method of synthesis of targeted lipid nanoparticle and uses thereof
JP2026512425A (ja) 2023-03-30 2026-04-16 オーエスイー・イミュノセラピューティクス 免疫細胞増強分子の発現のための活性化免疫細胞に標的化された脂質ベースのナノ粒子及びその使用
WO2024220712A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Vaccine compositions
WO2024220752A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Rna therapeutic compositions
EP4698150A1 (en) 2023-04-19 2026-02-25 Sail Biomedicines, Inc. Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
WO2024233308A2 (en) 2023-05-05 2024-11-14 Orna Therapeutics, Inc. Circular rna compositions and methods
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
WO2025006613A1 (en) * 2023-06-27 2025-01-02 Hopewell Therapeutics, Inc. Lipid nanoparticles for cancer immunotherapy
WO2025007148A1 (en) 2023-06-30 2025-01-02 Orna Therapeutics, Inc. Polymer lipid nanoparticle compositions for delivering circular polynucleotides
CN122270557A (zh) * 2023-08-17 2026-06-23 武汉大学 稳定性与表达量增强的环状rna
WO2025049690A1 (en) 2023-08-29 2025-03-06 Orna Therapeutics, Inc. Circular polyethylene glycol lipids
EP4771154A2 (en) 2023-09-01 2026-07-08 Renagade Therapeutics Management Inc. Gene editing systems, compositions, and methods for treatment of vexas syndrome
CN122497525A (zh) 2023-11-07 2026-07-31 欧纳医疗公司 环状rna组合物
WO2025106930A1 (en) 2023-11-17 2025-05-22 Sail Biomedicines, Inc. Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
WO2025106915A1 (en) 2023-11-17 2025-05-22 Sail Biomedicines, Inc. Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
WO2025117969A1 (en) 2023-12-01 2025-06-05 Orna Therapeutics, Inc. Process for manufacturing lipid nanoparticles
WO2025128871A2 (en) 2023-12-13 2025-06-19 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2025133115A1 (en) 2023-12-21 2025-06-26 Ose Immunotherapeutics Lipid-based nanoparticles comprising il-35
CN120290557A (zh) * 2024-01-11 2025-07-11 深圳近邻生物科技有限公司 一种通用的且无“scar”的RNA环化方法
WO2025155753A2 (en) 2024-01-17 2025-07-24 Renagade Therapeutics Management Inc. Improved gene editing system, guides, and methods
WO2025166238A1 (en) 2024-01-31 2025-08-07 Orna Therapeutics, Inc. Fast-shedding polyethylene glycol lipids
WO2025179198A1 (en) 2024-02-23 2025-08-28 Sail Biomedicines, Inc. Circular polyribonucleotides and unmodified linear rnas with reduced immunogenicity
WO2025218812A1 (en) * 2024-04-19 2025-10-23 Shanghai Circode Biomed Co., Ltd. Novel internal ribosome entry sites and uses thereof
WO2025250751A1 (en) 2024-05-31 2025-12-04 Orna Therapeutics, Inc. Circular rna compositions and methods
CN118703488A (zh) * 2024-06-20 2024-09-27 毕昇(北京)生物科技有限公司 一种环状rna的纯化方法
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026006593A1 (en) 2024-06-28 2026-01-02 Orna Therapeutics, Inc. Synthetic internal ribosome entry sites
WO2026072709A1 (en) 2024-09-25 2026-04-02 Orna Therapeutics, Inc. Chimeric antigen receptors targeting bcma
WO2026068705A1 (en) 2024-09-26 2026-04-02 Ose Immunotherapeutics Lipid-based nanoparticles comprising non-glycosylated fc domains and uses thereof
GB202415784D0 (en) * 2024-10-25 2024-12-11 Rnavate Ltd Methods for purifying circular ribonucleic acid (RNA)
WO2026093414A1 (en) 2024-10-30 2026-05-07 Ose Immunotherapeutics Lipid-based nanoparticles comprising membrane il-35
WO2026096738A1 (en) 2024-10-31 2026-05-07 Orna Therapeutics, Inc. Chimeric antigen receptors targeting cd19
US20260115324A1 (en) * 2024-10-31 2026-04-30 Orna Therapeutics, Inc. Chimeric Antigen Receptors Targeting CD19
WO2026122418A1 (en) 2024-12-02 2026-06-11 Orna Therapeutics, Inc. Circular rna compositions and methods
WO2026122685A1 (en) 2024-12-03 2026-06-11 Orna Therapeutics, Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2026165530A1 (en) 2025-02-03 2026-08-06 Renagade Therapeutics Management Inc. Hydrophilic polymer lipids for use in lipid nanoparticles
CN119876152B (zh) * 2025-02-10 2026-07-24 毕昇(北京)生物科技有限公司 一种环状rna、嵌合抗原受体t细胞和构建方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319494B1 (en) 1990-12-14 2001-11-20 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
IL104570A0 (en) 1992-03-18 1993-05-13 Yeda Res & Dev Chimeric genes and cells transformed therewith
EP1027069B1 (en) 1997-10-29 2006-07-26 Genzyme Corporation Gene therapy for gaucher disease
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
EP1261379A2 (en) 2000-02-17 2002-12-04 Genzyme Corporation Genetic modification of the lung as a portal for gene delivery
AU2002368077B2 (en) 2001-07-12 2010-03-04 Jefferson Foote Super humanized antibodies
US20040014194A1 (en) 2002-03-27 2004-01-22 Schering Corporation Beta-secretase crystals and methods for preparing and using the same
EP1791865B1 (en) 2004-06-29 2010-07-28 Immunocore Ltd. Cells expressing a modified t cell receptor
US10059655B2 (en) 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2017222911A1 (en) * 2016-06-20 2017-12-28 The Board Of Trustees Of The Leland Stanford Junior University Circular rnas and their use in immunomodulation
WO2019081383A1 (en) 2017-10-25 2019-05-02 Universität Zürich EUCARYOTE 4 INITIATION FACTOR RECRUITMENT APTAMERS FOR ENHANCED TRANSLATION
US20190314291A1 (en) 2018-01-30 2019-10-17 Modernatx, Inc. Compositions and methods for delivery of agents to immune cells
IL276322B2 (en) 2018-02-01 2024-12-01 Tufts College Lipid-like nanocomplexes and uses thereof
WO2019191780A1 (en) 2018-03-30 2019-10-03 Arcturus Therapeutics, Inc. Lipid particles for nucleic acid delivery
CN112399860B (zh) * 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
JP7686574B2 (ja) * 2019-05-22 2025-06-02 マサチューセッツ インスティテュート オブ テクノロジー 環状ｒｎａ組成物及び方法

Similar Documents

Publication Publication Date Title
US11939580B2 (en) Construct of self-circularization RNA
JP7754721B2 (ja) 標的ｒｎａを編集するための機能性領域を付加したアンチセンス型ガイドｒｎａ
CN111629760B (zh) 包含rna治疗剂的外泌体
Kuai et al. Circular bivalent aptamers enable in vivo stability and recognition
JP2022546592A5 (enExample)
JP7675451B2 (ja) 安全を確保しながら転移性がんまで効果的に治療可能な、搭載する免疫誘導遺伝子の最適発現レベルを与える発現制御システムを有する腫瘍溶解性ウイルス（腫瘍溶解性免疫治療）
CN112334156A (zh) 用于亲和纯化的工程细胞外囊泡
CN115151277A (zh) 负载核酸的红细胞细胞外囊泡
CN110869498A (zh) 经由核递送crispr/cas9导向编辑细胞rna
JP2020513784A5 (enExample)
US20230181620A1 (en) Compositions for translation and methods of use thereof
CA3140594A1 (en) Methods of dosing circular polyribonucleotides
JP2024518100A5 (enExample)
WO2023242425A1 (en) Compositions and methods for circular rna affinity purification
EP4585690A1 (en) Self-circularization rna structure
JP2024534216A (ja) Ｒｎａアフィニティー精製のための組成物および方法
CN115869332A (zh) 递送至体内后在肝脏少表达的mRNA药物及其制备方法
WO2025102994A1 (zh) 基于i型内含子的rna体外环化与滚环翻译的方法及其应用
US20230272416A1 (en) Method and system for delivering nucleic acid
JP2024529930A5 (enExample)
TW202540418A (zh) 新穎ｒｎａ構建體及使用其製備環狀ｒｎａ的方法
WO2026098109A1 (zh) 一种无疤痕环状核酸分子的制备方法及其在靶向递送中的应用
HK40082089A (en) Nucleic acid loaded red blood cell extracellular vesicles
CN120519490A (zh) 一种新型杂交dna载体及其应用
WO2025011502A1 (zh) 制备环状rna方法及用于所述方法的核酸序列